Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject

PHASE1CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy
Interventions
DRUG

AZD1446

Oral solution Dose single and followed by 7-day multiple dosing.Specific doses depend on panel.

DRUG

Placebo

Oral solution Dose single and followed by 7-day multiple dosing.

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY